Title
Category
Credits
Event date
Cost
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies. The vicious cycle of cardiorenal anemia syndrome (CRAS)—the pathologic triad wherein the three conditions are each capable of causing and/or being caused by the other—can be effectively mitigated and managed with IV iron.
  • Cardiology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies. The vicious cycle of cardiorenal anemia syndrome (CRAS)—the pathologic triad wherein the three conditions are each capable of causing and/or being caused by the other—can be effectively mitigated and managed with IV iron.
  • Cardiology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
$0.00
In this Expert Exchange-based format, activity attendees will be immersed in a lively discussion between key thought leaders in the world of HF.
  • Cardiology
  • Nephrology
  • ANCC
  • Participation
$0.00
This session will provide expert guidance across the totality of the hyperkalemia management paradigm, starting with a review of the calculus as a whole, then focusing specifically on acute care settings, with emphasis on emerging cl
  • Cardiology
  • Nephrology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
02/07/2023
$0.00
To register in advance click here: https://us06web.zoom.us/webinar/register/WN_XH6_S93OR_urcjfuC_QZqgThis session will provide expert guidance across the totality of the hyperkalemia management paradigm, starting with a review of the calculus as a whole, then focusing specifically on acute care settings, with emphasis on emerging clinical trial evidence and practical pearls for implementing novel potassium binders into hospital-based care.
  • Cardiology
  • Nephrology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
02/09/2023
$0.00
This session will provide expert guidance across the totality of the hyperkalemia management paradigm, starting with a review of the calculus as a whole, then focusing specifically on acute care settings, with emphasis on emerging clinical trial evidence and practical pearls for implementing novel potassium binders into hospital-based care.
  • Cardiology
  • Nephrology
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit™
  • ANCC
  • ICPE
  • Participation
02/16/2023
$0.00
To register in advance click here: https://us06web.zoom.us/webinar/register/WN_VNGzcfn7R82xNQeCa7-szgThis session will provide expert guidance across the totality of the hyperkalemia management paradigm, starting with a review of the calculus as a whole, then focusing specifically on acute care settings, with emphasis on emerging clinical trial evidence and practical pearls for implementing novel potassium binders into hospital-based care.